Prof. Dr.
Marc Van Montagu,
Chairman,
International Plant
Biotechnology Organisation (IPBO), Gent University
and president of
the European
Federation of Biotechnology, told
journalists at a press conference in Brussels, today,
that Europe is missing out on the biotech revolution in
agriculture. Europe is lagging behind its worldwide
competitors and European farmers are deprived of access to
one of the fastest growing technologies in agriculture.
Marc Van Montagu is the inventor
of the technology to create genetically modified (GM) plants
and produced the first GM plant in Europe. He is convinced
that technology transfer and plant biotechnology research
oriented to the needs of the developing countries is
important: “Fighting the vicious circle of hunger and
poverty is the most urgent task that faces our society, and
will require a reformulation of current models of
agriculture,” he said.
The European Union is far
behind its competitors in terms of number of hectares under
GM cultivation. The new figures published last week by
the International Service for
the Acquisition of Agri-biotech Applications (ISAAA),
show that in 2005 the number of hectares globally cultivated
with GM crops increased by 9.0 million hectares. Among the
growing number of countries cultivating GM crops, five of
them are EU Member States, which is encouraging for
Europe but still
remains low in global terms.
Two of
Europe’s leading Agro biotech companies –
CropDesign and Devgen
– are in the frontline in developing and working on
agricultural biotechnologies. Both companies are strong
advocates for these technologies. Their R&D activities are
important for Europe in its quest towards a strong,
knowledge based economy. “The fact that Europe is lagging
behind in the commercialization of GM-crops doesn't make
things easier for young R&D driven companies”, says Johan
Vanhemelrijck,
EuropaBio Secretary General.” The question is how many
companies decided not to start up in this area in Europe,
and how many opportunities have we lost to maintain our
leadership?”
Dr Van Montagu praised the
European Commission supported European stakeholder forum on
plant genomics and biotechnology, “Plants
for the Future", which sets out a
20 year
vision and a Strategic Research Agenda for European
agricultural development for the next two decades as being a
good example of supporting the plant science research and
industry community who want to reap the benefits of
agricultural biotechnologies. All speakers hope that the
implementation of the EU regulation concerning GM-crops is
encouraging at the national level, which will open the way
towards a sustainable use of a very useful technology.
International Plant
Biotechnology Organisation (IPBO)
IPBO mission is training, technology transfer and
plant biotechnology research oiented towards the
needs of the developing countries.
ISAAA
The International Service for the Acquisition of
Agri-biotech Applications (ISAAA) is a
not-for-profit organization that delivers the
benefits of new agricultural biotechnologies to the
poor in developing countries. It aims to share
these powerful technologies to those who stand to
benefit from them and at the same time establish an
enabling environment for their safe use.
EuropaBio
EuropaBio, the European Association for
Bioindustries, has 60 direct members operating
worldwide and 25 national biotechnology associations
representing some 1500 small and medium sized
enterprises involved in research and development,
testing, manufacturing and distribution of
biotechnology products.
Flanders
Interuniversity Institute for Bioechnology (VIB)
VIB is a non-profit
scientific research institute. Using advanced gene
technology, VIB studies the functioning of the human
body, plants and microorganisms.